DocDollars

Colgate Oral Pharmaceuticals, Inc.

NY · United States · Reporting entity ID 100001351953

Total reported 2019–2025
$1.37M
#1,192 of 2,960 reporting companies — 0% of all reported industry payments
$1.37M in general payments across 47,536 records.

How it breaks down

General payments $1,367,781

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Colgate Oral Pharmaceuticals, Inc. reported $1.37M to US doctors and teaching hospitals from 2019 to 2025, ranking #1,192 of 2,960 reporting companies. All of it was general payments such as consulting, speaking, food and travel. 47,536 general payment records were filed.

Common questions about Colgate Oral Pharmaceuticals, Inc.

How much has Colgate Oral Pharmaceuticals, Inc. paid US doctors?

Colgate Oral Pharmaceuticals, Inc. reported $1,367,781 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $1,367,781 in general payments.

How does Colgate Oral Pharmaceuticals, Inc. rank among drug and device companies?

It ranks #1,192 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Colgate Oral Pharmaceuticals, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.